CD8+ as a Predictive Factor for Response to Anthracycline-Based Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer at Dr. Soetomo General Hospital, Surabaya, January 2024-August 2025. (2025). Vascular and Endovascular Review, 8(13s), 155-161. https://doi.org/10.64149/